4.3 Review

Kisspeptin as a potential biomarker throughout pregnancy

Publisher

ELSEVIER
DOI: 10.1016/j.ejogrb.2019.07.016

Keywords

Kisspeptin; Pregnancy; Placenta; Pre-eclampsia; Miscarriage

Funding

  1. National Key R&D Program of China [2016YFC1000201, 2016YFC1000601]
  2. National Natural Science Funds for general program [31501201, 81471427, 81771650, 81571400, 81771580]

Ask authors/readers for more resources

Kisspeptins are a family of neuropeptides that are critical for the puberty initiation and female fertility. Plasma or serum kisspeptin is mainly derived from the placenta during pregnancy and plasma kisspeptin levels significantly increase across pregnancy. Plasma kisspeptin levels could be used as a potential biomarker for the detection of miscarriage, pre-eclampsia, gestational trophoblastic neoplasia (GTN), and fetal development. Kisspeptin may also be involved in the process of parturition by stimulating oxytocin secretion during term pregnancy. This review discussed the potential use of kisspeptin as a marker across pregnancy and highlighted the unresolved problems in this area. Tweetable abstract: Plasma kisspeptin levels could be used as a potential biomarker across pregnancy. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available